
TVM Life Science Management GmbH
Phone: +49–89-99 89 92–00 | Contact: Dr Hubert Birner · info@tvm-capital.com
www.tvm-lifescience.com
Industry sectors
Pharmaceutical, biopharmaceutical, medical technology, diagnostics
Profile
TVM is a leading international venture capital firm focused on invest¬ing in life science innovations. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC), that leverages the firm’s strate¬gic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
Services
TVM actively invests in lasting partnerships providing portfolio companies what they each need to succeed: recruiting new management and board members, honing development plans and product registration strategies, finding potential partners and carrying out financing and exit strategies. TVM has a global network of entrepreneurs who are available as management resources, key opinion leaders and everyday contact partners providing corporate finance advice and experts for all relevant specialist areas.